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Zonula Occludens (ZO) proteins are ubiquitous scaffolding proteins providing the structural basis for the assem-
bly of multiprotein complexes at the cytoplasmic surface of the plasma membrane and linking transmembrane
proteins to the ﬁlamentous cytoskeleton. They belong to the large family of membrane-associated guanylate
kinase (MAGUK)-like proteins comprising a number of subfamilies based on domain content and sequence
similarity. ZO proteins were originally described to localize speciﬁcally to tight junctions, or Zonulae Occludentes,
but this notion was rapidly reconsidered since ZO proteins were found to associate with adherens junctions
as well as with gap junctions, particularly with connexin-made intercellular channels, and also with a few
other membrane channels. Accumulating evidence reveals that in addition to having passive scaffolding
functions in organizing gap junction complexes, including connexins and cytoskeletals, ZO proteins (particularly
ZO-1) also actively take part in the dynamic function as well as in the remodeling of junctional complexes in a
number of cellular systems. This article is part of a Special Issue entitled: Reciprocal inﬂuences between cellTRP cytoskeleton and membrane channels, receptors and transporters. Guest Editor: Jean Claude Hervé.
© 2013 Elsevier B.V. All rights reserved.Contents
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Zonula occludens (ZO) proteins are ubiquitous scaffolding proteins
providing the structural basis for the assembly of multiprotein
complexes at the plasma membrane. They belong to the large family
ofmembrane-associated guanylate kinase (MAGUK)-like proteins com-
prising a number of subfamilies based on domain content and sequence
similarity. Fanning and Anderson [1] hypothesized that MAGUK pro-
teins would cluster ion channels, receptors, adhesion molecules and
cytosolic signaling proteins at speciﬁc membrane domains and tightly
link these proteins to the cytoskeleton. Such cytoskeletal docking
restricts ion transport proteins (channels, transporters) to specialized
domains of the plasma membrane. ZO proteins, present only in multi-
cellular organisms, associate among themselves andwith other integral
and adaptor proteins of the tight junctions, of the adherens junctions
and of gap junctions, as with numerous signaling proteins and the actin
cytoskeleton.
Protein–protein interactions occurring via the recognition of short
peptide sequences by modular interaction domains play a central
role in the assembly of signaling protein complexes and larger protein
networks that regulate cellular behavior. ZO proteins, comprising
ZO-1, -2, and -3, are ubiquitous peripheral proteins localizing at
junctional sites. ZO proteins are multi-domain scaffolds that bind
directly various types of proteins to the cytoplasmic surface of the
junction and connect (either directly or indirectly) transmembranous
junctional proteins with the actin cytoskeleton. ZO proteins were origi-
nally described to localize speciﬁcally to tight junctions (TJs or zonulae
occludentes [2]) but this notion was rapidly reconsidered since these
proteins were found to associate with the cadherin-based adherens
junctions in cells lacking TJs, then later with gap junctions (GJs),
particularly with connexin-made intercellular channels (for review,
see [3]) and with a few membrane channels. In GJs, accumulating
evidences indicate that in addition to having passive scaffolding
functions in organizing GJ complexes, including connexins and
cytoskeletals, ZO proteins, particularly ZO-1, also actively take part in
the dynamic function as well as in remodeling of GJs in a number of
cellular systems.
2. The Zonula Occludens protein family
ZO proteins belong to the superfamily of MAGUK-like proteins,
which comprises a number of subfamilies based on domain content
and sequence similarity and plays essential roles in organ development,
cell–cell communication, cell polarity establishment and maintenance,
and cellular signal transduction. ZO-1, with a molecular mass of
220 kDa, was the ﬁrst TJ-associated protein to be identiﬁed. ZO-1
associates with ZO-2, a 160 kDa protein and the 130 kDa protein
ZO-3. The three ZO proteins have been inactivated in mice; ZO-3
knockout mice lack an obvious phenotype whereas animals deﬁcient
in ZO-1 or ZO-2 show early embryonic lethality.
3. Protein–protein interaction modules of ZOs
ZO proteins have an N-terminal half with a domain structure similar
to other MAGUK proteins, characterized for presenting a core of three
domains: (i) PDZ, an acronym combining the ﬁrst letters of three
proteins which were ﬁrst discovered to share the domain: the post
synaptic density protein 95 (PSD95) also known as synapse-associated
protein 90 (SAP90), the Drosophila septate junction protein Discs-large
(Dlg), and the epithelial tight junction protein Zonula occludens-1,
(ii) SH3 (the Src homology 3 domain) and (iii) guanylate kinase (GuK).
3.1. PDZ domains
Although originally identiﬁed in metazoans, PDZ domains have
been found to be spread through bacteria, fungi and plant lineagesas well (for review, see [3]). PDZ domains (80–100 amino acid resi-
dues) play a key role in cellular signaling. The second PDZ domain
of ZO proteins is responsible for the homo and hetero dimerization
of these molecules [4,5]. The most common function of PDZ domains
is their ability to bind to a short stretch of amino acid residues at the
C-termini of target proteins. While their primary sequence can differ
markedly, the three-dimensional structure of PDZ domains is remark-
ably conserved. The PDZ domain groove ends with a hydrophobic
cavity to which the predominantly, but by no means exclusively, hy-
drophobic side chain of the C-terminal end residue of the partnering
protein inserts. Indeed, the nature of this pocket appears to have con-
siderable inﬂuence on the speciﬁcity of partnerships that a particular
PDZ domain can undergo (see [6]). Moreover, certain PDZ domains
appear to be able to bind phosphatidylinositol 4,5-bisphosphate
(commonly known as PIP2), and cyclic peptides [7], leading to the
possibility for some small molecules and biologics to be able to manipu-
late PDZ domain functioning.
3.2. SH3 domain
The Src homology 3 domain is a small (about 60 amino acid residues),
non-catalytic protein module shared among diverse signaling and
cytoskeletal proteins of eukaryotes. The best-characterized function
of SH3 domains is to bind proline-enriched sequences of the type
P-x-x-P (x, any residue), mediating the assembly of large multi-protein
complexes.
3.3. GuK domain
GuK (guanylate kinase) domains exhibit sequence similarity to
guanylate kinase, which converts GMP to GDP using ATPase as a
phosphate donor, but several studies suggest that the GuK domain
of MAGUK proteins has evolved into a protein–protein binding domain.
Ca-calmodulin for example was found to bind to the GuK domain of
ZO-1 [8], leading Fanning and Anderson [9] to suggest that intracellular
calcium levels might control some ZO-1 functions.
The MAGUK SH3 domain frequently shows an atypical binding
speciﬁcity, it does not bind to proline-rich sequences but instead
forms an internal structure supramodule via an intramolecular inter-
action with the subsequent GuK domain [10,11]. This SH3-hinge-GuK
unit is unique among MAGUK proteins. The sequence is indeed much
longer than 30 other MAGUKs and not homologous to these (see [12]).
According to these authors, proteins with different regulatory potential
(e.g. G-proteins and G-protein regulators) might adhere to and inﬂu-
ence cellular functions of ZO-proteins, and the interactions can be
modulated via its hinge region and/or the binding proteins.
ZOs also carry a proline-rich region located either at the C-termini
(ZO-1, ZO-2) or between the second and third PDZ domain (ZO-3)
[13]. Positioned between the conserved domains of MAGUKs are
highly variable sequences termed “unique” (U) motifs; starting from
the N-terminus these are Unique-1 (U1), followed by U2 between the
ﬁrst and second PDZ domains, etc.
The C-terminal regions are unique to the three ZOs and not present
in MAGUK proteins such as PSD95, calcium/calmodulin-dependent
serine protein kinase (CASK), and Dlg. Although highly divergent at
the amino acid level, the C-terminal regions all bind directly to F-actin
or with other actin-binding proteins, such as protein 4.1 and cortactin
[14].
4. Interactions of Zonula Occludens proteins with membrane
channels
The members of the superfamily of transient receptor potential
(TRP) cation channels are involved in a plethora of cellular functions.
One member of the “canonical” subfamily TRP channels, TRPC4, was
found to interact with the PDZ1 domain of ZO-1 [15]. A “nearly perfect”
Table 1
Reported interactions of channel proteins with ZO proteins.
Partner protein Via its Channel protein Protein motif Main approachesa Cell typesb References
ZO-1 PDZ-1 TRPC4 C-terminal TRL motif cl ci Human fetal astrocytes in culture [15]
PDZ-2 Cx30 cl ci at Mouse brain and spinal cord [98]
PDZ-2 Cx31.9 The most C-terminal residues cl ci HEK 293 cells [99]
Cx32 cl ci Cultured rat hepatocytes [46]
PDZ-1 Cx36 Four C-terminal residues (SAYV) cl ci em at Mouse brain, HeLa cells [100]
PDZ-1 A 14-residue C-terminal fragment cl ci at HeLa cells, βTC-3, mouse pancreas and adrenal gland cells [32]
cl ci PC12 cells [101]
PDZ-1 cl ci Mouse retina, HeLa cells [52]
PDZ-1 Cx35 (orth. Cx36) Four C-terminal residues (SAYV) cl ci at Goldﬁsh brain sections, HeLa cells [102]
Cx40 cl ci Porcine vascular endothelial cells [103]
PDZs Cx43 C-terminal 5 residues cl ci at HEK 293 cells, rat cardiomyocytes [24]
PDZ-2 Extreme C-terminal cl ci dh COS-7, Rat-1, mink lung epithelial cells [25]
PDZ-2 C-terminal 5 residues cl ci em Rat adult ventricular myocytes [65]
cl ci 42GPA9 cells, rat testis lysates [104]
PDZ-2 C-terminal ci at C57B16 mouse cortical astrocytes [71]
PDZ-2 Last 19 C-terminal residues nmr [36]
PDZ-2 CT (residues at the -3 position) cl ci dh MDCK cells [35]
PDZ-2 cl ci at Mouse brain and spinal cord [98]
PDZ-2 C-terminal (amino acids 374–382) cl at HeLa cells, rat cardiomyocytes [27]
cl ci Porcine vascular endothelial cells [103]
PDZ-2 C-terminus cl ci NRK and HEK 293 cells [105]
cl ci at Human trophoblastic cells [95]
cl ci dl HeLa cells [55]
cl ci HeLa cells [106]
dl Neonatal rat ventricular myocytes [29]
cl ci Cultured bovine corneal endothelium cells [91]
Cx43, Cx45 cl ci at ROS 17/2.8 cells [44]
PDZs Cx45 C-terminal 4 residues cl ci dh MDCK cells [107]
12 most C-terminal residues cl ci at ROS 17/2.8 cells [108,109]
PDZ-2 cl ci at em HeLa cells [52]
PDZ-2 Cx46, Cx50 Most C-terminal residues cl ci Mouse lens [110]
PDZ-2 Most C-terminal residues cl ci em at Mouse lens [111]
PDZ-2 Cx47 cl ci em at Mouse brain, HeLa cells [112]
ZO-2 PDZ-1 Cx36 Four C-terminal residues (SAYV) cl ci at HeLa and βTC-3 cells [34]
Cx43 C-terminal end at NRK cells [113]
PDZ-2 Cx43 C-terminal end cl ci dh NRK, HEK 293T cells, heart tissues [30]
ZO-3 PDZ-1 Cx36 Four C-terminal residues (SAYV) cl ci at HeLa and βTC-3 cells [34]
PDZs Cx45 C-terminal 4 residues cl ci dh MDCK cells [107]
a cl: co-localization; ci: co-immunoprecipitation; fs: co-fractionation or co-sedimentation; dh: double hybrid; dl: duolink; em: electrommicroscopy immuno labeling: at: afﬁnity
techniques (pull-down, afﬁnity binding assays, surface plasmon resonance); nmr: nuclear magnetic resonance.
b In roman characters, cells where Cx were endogenously expressed; in italics, cells where Cx were exogenously expressed, surexpressed or mutated.
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release-activated” calcium channels) and ZO-1 was observed in mouse
pancreatic acini [16]. The observations made in Cav1.2-transfected en-
dothelial ECV cells suggested a robust interaction between ZO-1 and
the voltage-gated L-type Ca2+ channel Cav1.2 [17]. However, most of
the reported interactions of ZO proteins with channel-forming proteins
occur with connexins (Cxs), a family of structurally related transmem-
brane proteins that assemble to form chordate gap junctions. Each gap
junction channel is made of two hemichannels, or connexons, which
are themselves each constructed out of six connexin molecules. The as-
sembly of Cxs into GJs is amultistep process. The newly synthesized Cxs
are co-translationally inserted into the endoplasmic reticulum, they
oligomerize to form connexons, then connexons are delivered to the
cell surface either via Golgi and trans-Golgi network in small vesicles
(a model largely based on the studies on Cx43 and Cx32) (see [18]) or
via a Golgi-independent route for Cx26 [19] and Cx30 [20].
Hemichannels diffuse laterally within the membrane to cell-to-cell
border regions, where they dock with the connexons in the contiguous
cell membranes to form intercellular channels, which cluster to form a
GJ plaque. Because of the relatively short half-life of Cxs (usually
1.5–5 h, see [21]), the junctional plaque is in a dynamic state, constantly
remodeled through both recruitment of newly synthesized connexons
to the periphery and endocytosis of older plaque components from
the plaque center. Although much has been learned about these differ-
ent steps, the precise spatio-temporal events and the cellular factors
required for the docking of connexons, the de novo formation of anew plaque and its life cycle remain poorly understood (see [22,23]).
The activity of junctional channels is markedly inﬂuenced by intramo-
lecular modiﬁcations (e.g. by phosphorylations of proteins) and via
the formation of multiprotein complexes where pore-forming subunits
bind to auxiliary channel subunits and associate with scaffolding pro-
teins, particularly ZOs, that play essential roles in channel localization and
activity. These scaffolding proteins link signaling enzymes, substrates,
and potential effectors (such as channels) into multiprotein signaling
complexes that may be anchored to the cytoskeleton. Protein–protein
interactions play essential roles in channel localization and activity.
Cx43 was the ﬁrst connexin found to interact with a ZO protein
[24,25], and this interaction has been subsequently observed in a
variety of cell types and with different Cx isotypes (Table 1). Cx43/ZO-1
associations do not necessarily overlap directly with whole junctional
plaques, and ZO-1 has frequently been observed only at the plaque
perimeter [26–28], a region termed “perinexus” [29]. The fact that
ZO-2 also binds to the C-terminus of Cx43 [30] opens the possibility
of competition between these ZO proteins to interact with the
Cx43-PDZ-binding motif, to inﬂuence gap junctional patterning.
Conversely, a competition between Cx-protein partners or even between
Cxs and proteins belonging to other classes of junctional complexes
(e.g. tight junctions) still widens the possibilities of adaptations of
intercellular junctions to the cell needs.
As indicated in Fig. 1, connexins, except Cx36 (and its ﬁsh
ortholog, teleost Cx35), which interacts with PDZ1 of ZO-1, namely
Cx30, -31.9, -43, -46, -47 and -50, mainly interact with PDZ2 of ZO-1
PFig. 1. Domain organization of the ZO proteins. The canonical MAGUK protein binding motifs (Psd95/Discs large/Zonula, PDZ; Src homology3 domain, SH3; Guanylate kinase-like
domain, GuK) are separated by “unique” regions of high sequence diversity. Some channel proteins interacting with ZO proteins (e.g. Cx32, Cx40 and Cx45) are not included in the
ﬁgure since their association domain is less well described.
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teract with ZO-3 (see Table 1). In Cx30-HeLa cells however, if tubulin
and actin were co-precipitated with Cx30, ZO-1 protein was not [20].
In contrast with these other connexins, Cx36 contains the C-terminus
amino acids Y-V, the binding motif domain present in the C-terminus of
most of the claudins and reported to be responsible for their interaction
with the PDZ-1 domain of ZOs [31]. A domain of 14 C-terminus amino
acids (and particularly the last 4 ones) of the Cx36 sequence appeared
to be required for Cx36 interaction with the PDZ-1 domain of ZO-1
since a peptide corresponding to this region showed binding capacity
to the PDZ-1 domain of ZO-1 and behaved as a competitive inhibitor of
Cx36/ZO-1 interaction in vitro [32]. In the retina of Cx36−/−mice, la-
beling of ZO-1 was only slightly reduced whereas a large reduction of
ZO-2 and ZONAB (ZO-1-associated nucleic acid-binding protein)was
observed [33]. These results suggest a direct interaction of Cx36 with
ZO-2 and/or ZONAB rather than with ZO-1. Cultured βTC-3 and
Cx36-transfected HeLa cells express ZO-2 and ZO-3 and display
co-association of Cx36/ZO-2 and Cx36/ZO-3 at points of cell–cell
contacts forming gap junction plaques. Molecular interaction of Cx36
with each of these ZO proteins occurs by tethering of the PDZ domain
binding motif in Cx36, represented by the C-terminus SAYV amino
acids in this protein, selectively to the PDZ-1 but not to the PDZ-2 or
PDZ-3 domains contained in each of ZO-2 and ZO-3 [34].
Cx43 association with ZO-1 occurs via its extreme CT; Jin et al. [35]
suggested that this interaction would take place through a typical
Class II PDZ binding domain. Nuclearmagnetic resonance (NMR) titration
experiments determined that the ZO-1 PDZ-2 domain affected the last 19
amino acid residues of the CT of Cx43 [36]. Jin et al. [35] emphasized the
fact that Cx31.9, Cx43, Cx46 and Cx50 exhibited similar PDZ binding
motifs (DLXI) in their CT.
ZO-1 binding by Cx43 was lost when phenylalanine residues were
substituted for 375Pro and 377Pro, showing that Cx43 localization to a
gap junction implies a speciﬁc structural conformation at residues
374Arg–379Asp that is also important for ZO-1 binding [37]. 210Glu of
ZO-1 PDZ2 was found to be a key regulatory point in Cx43 binding
and phosphorylation-induced dissociation [38].
Chen et al. [39] solved the crystal structure of ZO-1 PDZ2 in com-
plex with a 9 aa C-terminal peptide of Cx43 (NH2-RPRPDDLEI-COOH).
The structure revealed that the domain swapping of ZO-1 PDZ2 generates
a distinct Cx43-binding site distal to the canonical PDZ ligand-binding
pocket. Importantly, the distal Cx43-binding sites in the PDZ2 dimer not
only provide unprecedented interaction speciﬁcity between Cx43 andZO-1 PDZ2 but also function as regulatory sites for the dynamics of the
Cx43/ZO-1 GJs.
Complementary biochemical studies showed that a longer peptide
(12 aa, NH2-ASSRPRPDDLEI-COOH, including the completely con-
served −9Ser and −10Ser) had higher binding afﬁnity to PDZ2.
Moreover, the phosphorylation of the upstream residues −9Ser or the
removal of −10Ser and −9Ser from the Cx43 peptide (the nine-residue
peptide) signiﬁcantly reduced the amplitude of the peptide binding
[39].
As −9Ser and −10Ser have been reported to be substrates of several
protein kinases, including protein kinases C (PKC) and B (PKB or Akt)
[40–42], Chen et al. [39] suggested that the phosphorylation of the
two Ser residues (−9Ser in particular) can indeed weaken the binding
between Cx43 and ZO-1 PDZ2. Considering the polyvalent properties
of both Cx43 in connexons and ZO-1 PDZ2, the impact of −9Ser
and/or −10Ser (corresponding to respectively 372Ser and 373Ser)
phosphorylation of Cx43 on its ZO-1 binding (that is, decrease in
the binding) is very large. Therefore, Chen et al. [39] suggested that
the phosphorylation/dephosphorylation of these serine residues on
Cx43 can be readily used as an on/off switch for the Cx43–ZO-1 com-
plex formation.
Rhett et al. [43] observed an interaction of Cx43 with Nav1.5 sodi-
um channels in the perinexus of rat cardiomyocytes; as if Cx43/ZO-1
interaction was important in this domain, Nav1.5/ZO-1 was, at best,
very rare and the authors suggested that Cx43 interaction with
Nav1.5 would be mutually exclusive with Cx43/ZO-1 interaction.
As ZO-1 was able to bind to a truncated Cx45 protein lacking the
canonical PDZ domain-binding present at the C-tail, Laing et al. [44]
suggested that Cx45 might have a large and complex binding site
for ZO-l, comprising the residues between amino acid 357 and the
Cx45 C-terminus, an alternative possibility being the existence of 2
distinct binding sites, one involving the C-tail and the second the
amino acids proximal to amino acid 360. The authors however did
not exclude either the possibility of an artifactual ZO-1/Cx45 binding
or of an indirect interaction (e.g. an association of Cx45 with Cx43
bound to ZO-1). Lens Cx50 undergoes in vivo, during ﬁber matura-
tion, a natural proteolytic cleavage at residue 290 [45], which would
be expected to eliminate ZO-1 binding.
Cx32 was reported to interact with ZO-1 in primary rat hepatocytes
[46] but Jin et al. [35] noticed that the basis for the Cx32/ZO-1 interac-
tion differed from that of the Cx43, -40 and -45 interactions in that it
did not involve a PDZ binding domain at the Cx32 C-terminus.
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have a similar binding pattern to that exhibited in the ZO-1 PDZ2/Cx43
complex, with however a lower afﬁnity [47] and, indeed, ZO-2 PDZ2
associates with Cx43 (see Table 1). Interestingly, ZO-2 PDZ2 also
interacts with PIP2 [48].
5. Roles of Zonula Occludens proteins
5.1. Inﬂuence on the strength of cell-to-cell communication
Several studies suggest that the Cx binding to ZO proteins (par-
ticularly ZO-1) may regulate gap junction assembly in a connexin- and
cell type-speciﬁc manner, at different steps.
5.1.1. Hemichannel assembly
Considering the long (B140 residues) and ﬂexible connecting
sequence between the transmembrane helix and the PDZ-binding
tail of Cx43, Chen et al. [39] proposed a model based on the assumption
that the existence of two Cx43-binding sites in the ZO-1 PDZ2 dimer
(which are≈3 nm apart), should be able to promote and stabilize the
assembly of six Cx43 molecules within one hemichannel as well as to
cluster multiple hemichannels distributed on plasma membranes for
the formation of functional GJs.
5.1.2. Trafﬁcking of junctional proteins
PDZ proteins, including ZOs, often exert an effect as adaptors in
linking their binding partners with cellular protein trafﬁcking
machineries, thereby regulating both the biogenesis and the cellular
localization of PDZ-interacting targets. Mitic et al. [49] constructed
chimeric proteins containing the tail of human occludin, with or without
the region that binds ZO proteins, fused to the membrane-spanning
portions of Cx32. They observed that chimeras containing the
ZO-binding domain of occludin targeted them to tight junction ﬁbrils.
In HeLa cells, small interfering RNAs (siRNAs) used to knock down
ZO-1 levels completely inhibited normal trafﬁcking of wild-type Cx50
and development of cell-to-cell communication [50].
5.1.3. Formation and localization of gap junctional plaques
Cytoplasmic scaffold proteins appear to play key roles in the assembly
of membrane specialized areas (e.g. cellular junctions, channel or recep-
tor clusters), organizing membrane proteins into specialized membrane
domains. Cytoskeletal-based perimeter fences were for example seen
to selectively corral a membrane-protein sub-population of potassium
channels (Kv2.1 channels) to generate stable 1–3 μ2 clusters [51]. These
authors noticed that despite the stability of these microdomains, the
channels retained within the cluster perimeter were surprisingly mobile,
showing that the clustering did not result from a static scaffolding-based
structure. ZO proteins are at the center of a network of protein interac-
tions, linked to the actin cytoskeleton via their CT and to Cxs via their
NT. In the mouse retina for example, ZO-1, interacting with Cx45 via
its PDZ2 domain and with Cx36 via its PDZ-1 domain, provides for
co-scaffolding of Cx45 with Cx36, forming “bihomotypic” gap junctions,
with Cx45 structurally coupled to Cx45 and Cx36 coupled to Cx36 [52].
The critical role of ZO-1 in mediating this association by tethering the
two Cxs within gap junctions was indicated by abolition of Cx36/Cx45
co-IP after removal of the C-terminal 4 aa residues of Cx36, required for
the interaction of Cx36 with the PDZ-1 domain of ZO-1 [52]. The fact
that ZO-1 and ZO-2 seem to compete throughout the cell cycle for associ-
ation with Cx43 led Singh et al. [30] to suggest that the ratio of ZO-1 and
ZO-2 interacting with Cx43 may inﬂuence the stability and/or stabiliza-
tion of gap junctions. Connexin channels clustered in gap junctional
plaques share these characteristics, where ZO-1 is preferentially localized
at the periphery of the Cx43 [26–28], or Cx50 [53] plaques, suggesting
that a ZO-1-actin perimeter fence could selectively corral gap junction
channels (Fig. 2).As ZO-1 can target to the periphery of Cx43 junctional plaque
independently of PDZ2-mediated interactions, Hunter and Gourdie [54]
put forward a targeting sequence that would initially involve ZO-1
bound to junctional complexes (possibly N-cadherin-based) adjacent
to GJs, followed by a transfer of ZO-1 and its direct engagement with
Cx43 at GJ edges. In Cx43-HeLa cells, actin co-immunoprecipitated
with ZO-1 only in the Triton-insoluble fraction, suggesting that ZO-1,
actin and Cx43 were present in the same multiprotein complex only
when connexons were aggregated in detergent-resistant GJs [55].
According to Chen et al. [39], the potential multimerization of ZO-1
through its SH3 and GuK domains should further increase its Cx43 GJ
formation capacity.
Toyofuku et al. [56] observed that functional GJs were formed
even when the Cx/ZO-1 interaction was prevented. In previous stud-
ies, the expression of truncated Cx43 lacking the site of ZO-1 binding
led to the formation of functional GJs [57,58]. Functional studies
showed normal dye transfer between myocytes isolated from mice
expressing Cx43D378stop (lacking the last ﬁve C-terminal aa resi-
dues, the binding motif for ZO-1) and unchanged electrical coupling
and dye transfer in Cx43D378stop HeLa cells [59]. But haplodeﬁcient
mice expressing a CT-truncated Cx43, incompetent to interact with
ZO-1, formed GJs at cardiac GJ plaques that were larger than those ob-
served in wild-type littermates [60]. In HeLa cells, siRNAs used to
knock down ZO-1 levels caused an unchecked accretion of undocked
connexons at the Cx43 plaque periphery, resulting in larger GJs and
fewer hemichannels [55] whereas it completely inhibited GJ forma-
tion by wild-type Cx50 [50]. In the latter study, Cx50 with PDZ-binding
motifmutations neither formGJ plaques nor induce cell–cell communica-
tion, whereas the addition of a seven-amino acid PDZ-binding motif
restored normal function to Cx50 lacking its entire C-terminal cytoplas-
mic domain.
In some cell types, gap junctions are preferentially located in
speciﬁcmembrane areas; in adult heart for example, Cx43 gap junctions
localize to the intercalated disk (IDs) of myocytes. The link between
Cx43 and α-spectrin, via ZO-1, was suggested to serve to localize Cx43
at the cardiac IDs [24]. In human squamous carcinoma cells, intimacy
between Cx43 and F-actin via ZO-1 seemed to be required to maintain
or stabilize GJ plaques, and ZO-1 knockdown attenuated GJ formation,
suggesting that direct or indirect cross-talk between Cxs and the actin
cytoskeleton via ZO-1 may be essential for GJ assembly [61].
5.1.4. Regulation of channel activity
Cx43-based cell-to-cell communication between Rat-1 ﬁbroblasts
was seen to be inhibited by depletion of PIP2, a compound functioning
as an intermediate in the inositol 1,4,5-triphosphate and diacylglycerol
(IP3/DAG) pathway, which is initiated by ligands binding to G protein-
coupled receptors activating the Gαq subunit. PIP2 is a substrate for
hydrolysis by phospholipase C (PLC). Inhibiting PIP2 hydrolysis kept
Cx43 channels open after receptor activation [62]. As ZO-1 binds
directly to the very C terminus of PLCβ3 via its third PDZ domain,
it was proposed to be a key intermediate in assembling Cx43 and
PLCβ3 into a complex, thereby facilitating regulation of Cx43 channel
function via PIP2 hydrolysis upon receptor activation [62]. In mouse
embryonic stem cells, siRNA-caused depletion of endogenous ZO-1 re-
duced GJIC intensively [63]. In N/N1003A cells, Akoyev and Takemoto
[64] noticed that ZO-1 was required for both PKCγ-driven disassembly
of Cx43 and effects on cell-to-cell dye transfer, that ZO-1 downregulation
induced abnormal interaction of PKC-γ with Cx43 without activation by
TPA (phorbol-12-myristate-13-acetate).
The F-actin cytoskeleton and actin-associated adapter proteins un-
derlying the cell membrane appear to regulate the function of mem-
brane complexes. In rat cardiac myocytes for example, the integrity of
the actin microﬁlament network is essential to preserve GJ communica-
tion [28]. In such processes, the F-actin-associated adapter proteins and
scaffolding proteins (particularly ZO-1) likelihood function as signal
transducers.
Fig. 2. Cx43/ZO-1 partnership about gap junctions. Artistic view of the perimeter fence attached to the cortical cytoskeleton that ZO-1 seems to form around the clustered
intercellular channels. The fragmentation of large gap junction plaques into small elements increases the Cx43/ZO-1 interaction.
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Earliest electronmicroscopy observations revealed that gap junction
fragments were degraded by internalization of a double-membrane
structure termed “annular junction” into one of the two cells, where
subsequent lysosomal or proteasomal degradation occurred, except in
some cases where the connexons were recycled. ZO-1 was suggested
to confer speciﬁcity to actin-based contractile processes via its ability
to simultaneously interact with Cx43 and cytoskeleton [65].
In 42GPA9 Sertoli cells, lindane (γ-hexachlorocyclohexane, a
lipid-soluble pesticide) enhanced the endocytic process, causing
an intracytoplasmic delocalization of the membranous signal for both
Cx43 and ZO-1, while localization of other tight junction proteins
(e.g. occludin or claudin) was not affected [66]. In the same cell line,
Gilleron et al. [67] noticed that if ZO-1 was usually localized on both
sides of the gap junction plaque, its presence became restricted to one
side of the junctional plaque during the endocytic GJ internalization
and the formation of annular junctions, suggesting that the dissociation
of ZO-1 fromCx43– preferentially on one side of the junctional plaque –
had a prominent role in GJ endocytosis. In HeLa cells stably expressing
tagged Cx43 (Cx43-YFP, Cx43 tagging being known to prevent ZO-1
binding), GJ internalization did not occur in response to inﬂammatory
mediators, showing that ZO-1/Cx43 interaction is required for GJ inter-
nalization [68].
42GPA9 Sertoli cells endogenously express Cx43 but transfection of
tagged Cx33 affected gap junctional communication by intracellular as-
sociationwith Cx43 and sequestration of the complex Cx43/Cx33 in the
early endosomes [69]. In wild-type Sertoli cells transfected with
Cx33-DsRed2 and Cx43-green ﬂuorescent protein vectors, heteromeric
Cx33/Cx43 hemi-channels were formed and incorporated into gap
junction plaques, but such plaques appeared unstable at this level
and were rapidly internalized [70]. The authors suggested that the
heteromeric Cx33/Cx43 complexmay interact less than the homomeric
Cx43 complex with ZO-1 because of the lack of binding site for ZO-1 on
Cx33. As among its described functions, ZO-1 is known to secure Cxs
in gap junction plaques at the cell–cell boundary, the reduced associa-
tion of ZO-1 with the Cx33/Cx43 complex could then explain the
Cx33/Cx43 gap junction plaque instability.
c-Src appears to inﬂuence the stability of GJ plaques via modiﬁ-
cations in the Cx43/c-Scr/ZO-1 complex, facilitating the GJ inter-
nalization [67,71,72] and subsequent degradation of annular junctions
[73]. According to Akoyev and Takemoto [64], the close proximity
of the 368Ser/PKCγ phosphorylation site to the ZO-1 PDZ-binding
domain on the Cx43-CT suggests that ZO-1/Cx43 effects and PKCγ
effects may be connected, ZO1 being able tomodulate the interaction
of PKCγwith Cx43 and, thus, the PKCγ-driven gap junction disassemblyof Cx43. Consequences of the binding of the c-Src SH3 domain to Cx43
and to Cx40 differ on the interactions of these Cxs with ZO-1. It can
indeed disrupt the Cx43/ZO-1 interaction, leading to down-regulation
of GJIC [36,56,71] whereas it does not affect the Cx40-CT/ZO-1 PDZ-2
domain complex [74].
5.2. Effects on other biological processes
Besides the transmembrane diffusion of small molecules and
metabolites that support tissue homeostasis and electrical and
chemical signaling, gap junction proteins are, via their selective
protein–protein interactions, involved in the control of cell growth,
proliferation, apoptosis, and would serve as tumor suppressors. In the
model proposed by Solan and Lampe [75] for example in normal rat
kidney cells during their progression from G0/G1 through S phase and
into mitosis, Cx43 is at ﬁrst found predominantly at the plasma mem-
brane, assembled into “typical” gap junction plaques, associated with
both ZO-1 and ZO-2, at the plasma membrane. Then the assembly of
Cx43 into plaques becomes less efﬁcient, accompanied by a shift in
subcellular Cx43 localization and a decreased co-localization with ZO-1
while the ZO-2 interaction is maintained. When cells enter mitosis, GJIC
is interrupted and Cx43 is predominantly intra-cytoplasmic [75].
ZO proteins are known to be engaged in the transmission of signals
from the plasmamembrane to the nucleus to regulate gene expression.
ZO-1 is associatedwith the transcription factor ZONAB [76], while ZO-2
is with the transcription factors Jun, Fos and C/EBP [77]. The associa-
tion of ZOswith GJ proteins results in themembrane sequestration of
transcription factors and hence the inhibition of their transcriptional
activity.
6. Physiological consequences
6.1. Physiological modulation of the ZO-1–connexin partnership
In the mammalian retina, Puller et al. [53] noticed that ZO-1 formed
margins aroundGJ andwas closely associatedwith glutamate receptors,
and suggested that that glutamate released from the photoreceptors
might play a role in modulating the conductance of electrical synapses
in the outer plexiform layer of the retina.
In rat cardiac myocytes, the RhoA signaling pathway dynamically
modulates the permeability of Cx43-made channels: RhoA activation
was seen to rapidly enhance the strength of cell-to-cell communication
but reduce Cx43/ZO-1 co-localization whereas RhoA inhibition had op-
posite effects, GJIC down-regulation and enhancement of Cx43/ZO-1
co-localization [28]. In mouse primary cultures of astrocytes, a
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ZO-1/ZO-2/occludin multiprotein complexes; acute treatments of cells
with endothelin-1 or sphingosine-1-phosphate induced both an in-
crease in the amount of Cx43 linked to these complexes and a drastic
GJIC inhibition [78]. In mouse embryonic stem cells, siRNA-caused de-
pletion of endogenous ZO-1 reduced GJIC intensively [63].
6.2. ZO-1–connexin interactions in pathological conditions
As GJ channels are conduits for propagation of electric activity, the
cardiac speciﬁc pattern (GJs preferentially localized to the long ends
of the cells, in IDs) led to hypothesize that this localization was
important for the physiological anisotropic conduction of the heart. In
acquired adult heart disease (as ischemic heart disease or heart failure),
a gap junction remodeling is observed, with alterations in the distri-
bution of gap junctions and the amount and type of expressed Cxs, a
“lateralization” of GJs, suspected to be involved in alteration of conduc-
tion (for review see for example [79]).
This remodeling has been suggested to result from alterations
in Cx43/ZO-1 interaction [80,81]. ZO-1 forms with N-cadherin a
multiprotein complex which, according to Palatinus et al. [82], would
be a key determinant of stable localization of both adherens junctions
and gap junctions at the ID. This is consistent with previous observa-
tions that cardiac-speciﬁc deletion of N-cadherin led to alteration in
Cx40 and Cx43, disassembly of the ID structure and conduction slowing
and arrhythmogenesis in adult mice [83,84]. Hesketh et al. [85] observed
that GJs formed between the lateral membranes of cardiomyocytes with
increased frequency in a canine model of failing heart did not co-localize
with ZO-1 and cadherin. In transverse sections of normal dog epicardium,
ZO-1 extensively covered the ID region and Cx43 was found primarily
around the ends of the myocytes but after coronary occlusion, Cx43
localized to lateral membranes, causing decreased conduction velocity
and formation of an arrhythmogenic substrate, whereas disk regions
remained comprised of ZO-1 alone [81].
A mimetic peptide corresponding to the last 9 aa of the Cx43 tail
caused an increase in GJ plaque size mainly ascribed to unregulated ac-
cretion of connexons from nonjunctional pools, with a possible contri-
bution from increased plaque fusions [27]. In a model of cryoinjury of
mouse left ventricle, treatment with a peptide incorporating the last 9
aa of the Cx43-CT decreased stimulated arrhythmias such as ventricular
tachycardia or ﬁbrillation. Together with these effects on cardiac
electrical function, the peptide reduced ZO-1/Cx43 co-localization
and GJ lateralization in arrhythmia-prone tissues of the injury bor-
der zone [86]. However, the peptide effects on GJ remodeling may
not have only resulted from effects on ZO-1/Cx43 interaction, the
authors identiﬁed a novel peptide target, PKC-ε. The peptide increased
PKC-ε phosphorylation of a consensus target on the Cx43-CT, the serine
residue 368Ser. Consistent with the in vitro results, levels of phosphory-
lated 368Ser in the injury border zone were elevated signiﬁcantly above
controls within hours of peptide exposure, suggesting a potential regu-
latory interplay between PKC-ε and ZO-1 at the Cx43-CT [86]. In a rat
model of pressure overload hypertrophy, late stages were found to be
associated with a marked dephosphorylation of Cx43 accompanying
loss of association with ZO-1 and pronounced conduction delays [87].
Matrix metalloproteinases (MMPs) contribute to left ventricu-
lar remodeling after myocardial infarction; MMP-7, abundant in
cardiomyocytes and macrophages, was found capable of mediating
Cx43 cleavage, releasing small free peptides derived from the extreme
C-terminus of Cx43. This truncation did not impede connexon for-
mation but such connexons were not able to interact with ZO-1 [88].
Cancer was the ﬁrst pathology proposed to be associated with mal-
function of direct cell-to-cell communication. Many tumors are indeed
deﬁcient in gap junction function for abnormal connexins (induced
e.g. by Cx mutation, mRNA decrease or aberrant of Cxs), the abnormal
distribution of Cxs (in the cytoplasm rather than into membrane) and
the abnormal regulation by other proteins (for review, see [89]). In theSerW3 Sertoli cell line, DDT (1,1,1-trichloro-2,2-bis(p-chlorophenyl)
ethane), a non-genomic carcinogen, was seen to induce abnormal
disintegration of the GJ plaque and internalization of both Cx43 and
its partners (ZO-1 and N-cadherin), through the formation of clathrin-
dependent endocytic vacuoles [90]. Exposure of 42GPA9 Sertoli cells
to a non-genomic carcinogen (lindane) induced a GJ plaque internal-
ization that was associated with an increased interaction of c-Src
with Cx43 and a concomitant decreased Cx43/ZO-1 association, with
an efﬁcient inhibition of intercellular coupling [67]. In contrast, cultured
bovine corneal endothelial cells exposed to DNA-damaging agents
(e.g. mitomycin C), exhibited Cx43 accumulation in large GJ plaques,
with reduction of ZO-1 binding, and displayed increased plaque stability
[91].
Applied to acute skin lesions, the mimetic peptide corresponding
to the last 9 amino acids of the Cx43 tail was reported [92] to accelerate
wound healing while reducing scar formation in a mouse model of
cutaneous injury, but the peptide effects on wound healing were in
some respects not similar to those reported for Cx43 antisense treatment
[93], making unclearwhether the Cx43 antisense or the peptide designed
to target ZO-1 acted via related mechanisms.
Xu et al. [94] rescued the embryonic lethality of ZO-2 knockout
mice by injecting ZO-2(−/−) embryonic stem cells into wild-type
blastocysts to generate viable ZO-2 chimeras. Adult chimeras presented
a set of phenotypes in different organs; in particular, male ZO-2
chimeras show reduced fertility and pathological changes in the
testis. The pre-dominant localization of Cx43 to the region of the
blood–testis barrier for example was perturbed, and the protein
was readily detected in the adluminal domain. Because Cx43 is essential
for the initiation and maintenance of spermatogenesis, Xu et al. [94]
suggested that its perturbed localization in ZO-2 chimera tubules may
contribute to the reduced fertility of ZO-2 chimera males.
In human trophoblastic primary culture, gene inactivation for ZO-1
using siRNA caused a signiﬁcant decrease in Cx43, suggesting that ZO-1
expression may be a prerequisite for Cx43 expression. And since Cx43
expression is associated with trophoblastic cell differentiation, ZO-1
siRNA treatment resulted in a large number of non-aggregated mono-
nuclear cells [95].
7. Conclusions and perspectives
The cytoplasmic adapter proteins ZOs are capable of assembling a
variety of membrane-associated proteins and signaling molecules in
short-lived functional units. Their requirement (particularly of ZO-1)
for the formation of GJ plaques and the establishment of intercellular
coupling varies between Cxs. For Cx50-mediated GJIC, an intact PDZ-
binding motif and ZO-1 are indispensable but has much less
importance in cell-to-cell communication via Cx46 channels [50],
and large GJ plaques are formed even when the Cx43/ZO-1 interaction
is prevented [55–60]. In this case, the area surrounding gap junction-
al plaques seems populated by unpaired connexons and ZO-1 appears
to regulate the size of gap junction plaques by limiting the
access of ZO-1-associated Cx43 into pre-existing gap junctions. More-
over, at least for Cx43, the functional interaction of the C-terminus of
the connexin with ZO-1 PDZ2 is essential for the GJ dynamic regulation.
The PDZ domains of ZO proteins play key roles in the assembly and
regulation of cellular signaling pathways. Moreover, their function can
be tuned by various means such as allosteric effects, disulﬁde bond
formation, auto-inhibition, competitive binding and phosphorylation
of PDZ domains and/or ligands, which pose PDZ domains as dynamic
regulators of cell signaling.
It is noteworthy that among gap junction proteins, only some
Cxs have up to now been reported to interact with ZO proteins.
In the animal kingdom indeed, three families of GJ proteins are
known, the well characterized Cxs in deuterostomes (Echinodermata,
Urochordata, Cephalochordata and Vertebrata), the innexins (“in-
vertebrate connexins”, Inxs) in protostomes (Nematoda, Mollusca,
602 J.-C. Hervé et al. / Biochimica et Biophysica Acta 1838 (2014) 595–604Platyhelminthes, Arthropoda, Annelida) at ﬁrst, then search of the
human genome revealed three Inx-related genes, and three correspond-
ing proteins, termed pannexins (Panxs), were identiﬁed (see [96]). Nei-
ther Inxs nor Panxs were until now seen to interact with ZO proteins,
but pannexin 1 directly interacts with actin (preferentially F-actin; [97]).References
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